Metabolic Dysfunction and Alcohol-related Liver Disease (MetALD): Position statement by an expert panel on alcohol-related liver disease - Journal of Hepatology journal-of-hepatology.eu/article/S0168-…

#MASLD raises CV risk- but how? 🧐 New data from Michelle T. Long and team show the Framingham Heart Study links hepatic steatosis & #liver fibrosis to impaired cardiorespiratory fitness, mediated by altered lipid metabolism & cardiometabolic pathways. onlinelibrary.wiley.com/doi/10.1111/li…

⚡️Discover the key highlights of the first publication on our new technology Guided VCTE™ integrated in our next generation #FibroScan® ➡️ "Guided VCTE™: an enhanced FibroScan® examination with improved guidance and applicability" Full article here: sciencedirect.com/science/articl…

Congratulations and a very Interesting study, any correlation to the genetic risk markers such as PNPLA3 for #MASLD or other liver related conditions which increase CAD risk. So often missed given blood’s poor indicators of liver health.

🚨 New study reveals shared genetic links between MASLD and cardiometabolic traits, highlighting lipid metabolism as a key factor in their comorbidity. #MASLD #Genomics #Cardiometabolic Read more: oaepublish.com/articles/mtod.…

⁦WestJet News⁩ ⁦WestJet⁩ ⁦PlazaPremiumHeathrow⁩ you may want to update the info as the lounge is not open to ⁦oneworld Alliance⁩ 🤔 the point of being in it then 🤔🤔🤔

This is great news and MyLife365.Me the liver app is a available in Ireland so people who have a #fibroscan can download the app, log their scan and track lifestyle and changes they make if it needs improvement or just keeping it #healthy Tawazun Health #liverhealth

Very encouraging and if this is you then track #lifestyle #diet #drink and #physicalactivity via MyLife365.Me FREE #liverhealth app and add your #fibroscan make the change, track the change and see the change 👍🏻

(4/5) “The numbers are eye-opening for almost every patient, and they’re powerful benchmarks I can use later to navigate progress and keep them motivated.”

The opportunity to translate the numbers seen on gaining a #Fibroscan and the discussion these initiate can be and are often life changing for many individuals Seeing the empowerment of an individual to address their health is a privilege and a rewarding experience

(1/3) ✨Exciting news in liver health: the FDA has accepted Echosens’ Letter of Intent to qualify LSM by VCTE (FibroScan®) as the first non-invasive surrogate endpoint in MASH clinical trials.

(2/3) This milestone opens a path for FibroScan® to ultimately replace liver biopsy for patient enrollment and treatment response assessment in MASH drug development—making participation in clinical trials less burdensome and more accessible for people living with MASH.

(3/3) Read our press release for full details: prnewswire.com/apac/news-rele… #FibroScanVCTE #MASH #ClinicalTrials #DrugDevelopment #LiverHealthMatters

The EASL Studio is back! Tune in this Wednesday 18:00 CEST as the faculty explore the relevance of alkaline phosphatase response, non-invasive fibrosis assessment, and composite scores like GLOBE and UK-PBC. Read more: easl.eu/easl-studio-ep… Marco Carbone Sven Francque

🧬 Study shows MASLD shares key genes & pathways with diabetes, obesity, and lipids—offering new drug targets. 🔗 oaepublish.com/articles/mtod.… #MASLD #Genetics #DrugDiscovery #LiverResearch

🔥 Beyond the liver: Metabolic and sex-specific factors may hold the key to personalized MASLD treatments. Time to rethink one-size-fits-all care! 🔗 oaepublish.com/articles/mtod.… #MASLD #MetabolicHealth #PrecisionMedicine #LiverResearch

Adding MyLife365.Me the FREE #liver #health app in 40 countries enables those who want to get tips and tricks that are #liver focused #MASLD #MASH #fattyliver

“Diet” foods aren’t always your friend when it comes to weight loss. Ultra-processed products like gluten-free snacks, fake meats, vegan cheeses, and protein bars can pack excess calories, sugars, and unhealthy fats - often undermining goals. Read my full comments on Medscape:

Impact of Semaglutide 2.4 mg on body composition and function: The SEMALEAN study shows 13% weight loss at 12 months with preserved lean mass, improved grip strength, and reduced sarcopenic obesity. Functional and metabolic health improved alongside fat loss.